Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Sep 1;182(3):789–799. doi: 10.1084/jem.182.3.789

Defective natural immunity: an early manifestation of human immunodeficiency virus infection

PMCID: PMC2192166  PMID: 7650485

Abstract

Cytotoxicity mediated by natural killer (NK) and lymphokine-activated killer (LAK) cells may be of significance in host defense against viral infections. This study included 347 patients infected with human immunodeficiency syndrome virus (HIV) type 1 and 110 controls. The NK cell activity, either unstimulated or stimulated with interferon-alpha (IFN-alpha) or interleukin-2 (IL-2), and the LAK cell activity were suppressed in patients, but the NK/LAK cell activity did not differ between patients with AIDS and patients without AIDS. However, the IFN- alpha-stimulated NK cell activity and LAK cell activity were reduced in patients with symptoms of HIV disease (CDCIV) when compared with asymptomatic patients (CDCII+III). When the data were analyzed by multiple linear regression, the percentage of CD4+ cells had a positive effect on these two parameters in patients without AIDS, whereas the percentage of CD4+ cells had no significant effect on unstimulated and IL-2-stimulated NK cell activity in these patients. In controls and AIDS patients, the percentage of CD4+ cells had no effect on NK/LAK cell activity in multiple linear models. The total number of CD16+ cells was low in patients compared to controls, whereas the percentages of CD16+, CD56+, and CD16+CD56+ were either normal or elevated. Therefore, the decrease in NK cell subpopulations did not contribute to the observed depression in NK/LAK cell activity in vitro. It is concluded that natural immunity is suppressed in HIV-seropositive patients primarily because of a qualitative defect of the NK/LAK cells. This qualitative defect includes a reduced responsiveness to IFN-alpha, which is progressive until the onset of symptoms, and possibly related to the loss of CD4+ cells.

Full Text

The Full Text of this article is available as a PDF (913.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonavida B., Katz J., Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. J Immunol. 1986 Aug 15;137(4):1157–1163. [PubMed] [Google Scholar]
  2. Brenner B. G., Dascal A., Margolese R. G., Wainberg M. A. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J Leukoc Biol. 1989 Jul;46(1):75–83. doi: 10.1002/jlb.46.1.75. [DOI] [PubMed] [Google Scholar]
  3. Brenner B. G., Gryllis C., Gornitsky M., Wainberg M. A. Changes in natural immunity during the course of HIV-1 infection. Clin Exp Immunol. 1993 Aug;93(2):142–148. doi: 10.1111/j.1365-2249.1993.tb07956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brenner B. G., Gryllis C., Wainberg M. A. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases. J Leukoc Biol. 1991 Dec;50(6):628–640. doi: 10.1002/jlb.50.6.628. [DOI] [PubMed] [Google Scholar]
  5. Cai Q., Huang X. L., Rappocciolo G., Rinaldo C. R., Jr Natural killer cell responses in homosexual men with early HIV infection. J Acquir Immune Defic Syndr. 1990;3(7):669–676. [PubMed] [Google Scholar]
  6. Cauda R., Tumbarello M., Ortona L., Kennedy R. C., Shuler K. R., Chanh T. C., Kanda P. Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptides. Nat Immun Cell Growth Regul. 1990;9(6):366–375. [PubMed] [Google Scholar]
  7. Chehimi J., Bandyopadhyay S., Prakash K., Perussia B., Hassan N. F., Kawashima H., Campbell D., Kornbluth J., Starr S. E. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. J Virol. 1991 Apr;65(4):1812–1822. doi: 10.1128/jvi.65.4.1812-1822.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chin T. W., Plaeger-Marshall S., Haas A., Ank B. J., Stiehm E. R. Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1989 Dec;53(3):449–459. doi: 10.1016/0090-1229(89)90007-x. [DOI] [PubMed] [Google Scholar]
  9. Doweiko J. P. Hematologic aspects of HIV infection. AIDS. 1993 Jun;7(6):753–757. doi: 10.1097/00002030-199306000-00001. [DOI] [PubMed] [Google Scholar]
  10. Fauci A. S. Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS). Clin Res. 1984 Dec;32(5):491–499. [PubMed] [Google Scholar]
  11. Fauci A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988 Feb 5;239(4840):617–622. doi: 10.1126/science.3277274. [DOI] [PubMed] [Google Scholar]
  12. Grimm E. A., Mazumder A., Zhang H. Z., Rosenberg S. A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982 Jun 1;155(6):1823–1841. doi: 10.1084/jem.155.6.1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gryllis C., Wainberg M. A., Gornitsky M., Brenner B. Diminution of inducible lymphokine-activated killer cell activity in individuals with AIDS-related disorders. AIDS. 1990 Dec;4(12):1205–1212. doi: 10.1097/00002030-199012000-00004. [DOI] [PubMed] [Google Scholar]
  14. Katz J. D., Mitsuyasu R., Gottlieb M. S., Lebow L. T., Bonavida B. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. J Immunol. 1987 Jul 1;139(1):55–60. [PubMed] [Google Scholar]
  15. Lifson J. D., Benike C. J., Mark D. F., Koths K., Engleman E. G. Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet. 1984 Mar 31;1(8379):698–702. doi: 10.1016/s0140-6736(84)92220-7. [DOI] [PubMed] [Google Scholar]
  16. Lusso P., Malnati M. S., Garzino-Demo A., Crowley R. W., Long E. O., Gallo R. C. Infection of natural killer cells by human herpesvirus 6. Nature. 1993 Apr 1;362(6419):458–462. doi: 10.1038/362458a0. [DOI] [PubMed] [Google Scholar]
  17. Mansour I., Doinel C., Rouger P. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1451–1457. doi: 10.1089/aid.1990.6.1451. [DOI] [PubMed] [Google Scholar]
  18. Oh S. K., Cerda S., Lee B. G., Blanchard G. C., Walker J. E., Hartshorn K. Partial purification and identification of an immunosuppressive factor in AIDS sera. AIDS Res Hum Retroviruses. 1993 Apr;9(4):365–373. doi: 10.1089/aid.1993.9.365. [DOI] [PubMed] [Google Scholar]
  19. Plaeger-Marshall S., Spina C. A., Giorgi J. V., Mitsuyasu R., Wolfe P., Gottlieb M., Beall G. Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS). J Clin Immunol. 1987 Jan;7(1):16–23. doi: 10.1007/BF00915420. [DOI] [PubMed] [Google Scholar]
  20. Rosenberg Z. F., Fauci A. S. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today. 1990 May;11(5):176–180. doi: 10.1016/0167-5699(90)90070-p. [DOI] [PubMed] [Google Scholar]
  21. Scott-Algara D., Vuillier F., Cayota A., Dighiero G. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells. Clin Exp Immunol. 1992 Nov;90(2):181–187. doi: 10.1111/j.1365-2249.1992.tb07925.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Scott-Algara D., Vuillier F., Cayota A., Rame V., Guetard D., Moncany M. L., Marasescu M., Dauguet C., Dighiero G. In vitro non-productive infection of purified natural killer cells by the BRU isolate of the human immunodeficiency virus type 1. J Gen Virol. 1993 Apr;74(Pt 4):725–731. doi: 10.1099/0022-1317-74-4-725. [DOI] [PubMed] [Google Scholar]
  23. Sirianni M. C., Soddu S., Malorni W., Arancia G., Aiuti F., Soddus S. Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol. 1988 Apr 15;140(8):2565–2568. [PubMed] [Google Scholar]
  24. Sirianni M. C., Tagliaferri F., Aiuti F. Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today. 1990 Mar;11(3):81–82. doi: 10.1016/0167-5699(90)90032-5. [DOI] [PubMed] [Google Scholar]
  25. Sugimoto M., Ohishi K., Ikawa Y. Cell-mediated immunity to BLV replication: analogous to HIV immunopathogenesis? Immunol Today. 1993 Apr;14(4):190–191. doi: 10.1016/0167-5699(93)90287-U. [DOI] [PubMed] [Google Scholar]
  26. Tóth F. D., Mosborg-Petersen P., Kiss J., Aboagye-Mathiesen G., Zdravkovic M., Hager H., Ebbesen P. Differential replication of human immunodeficiency virus type 1 in CD8- and CD8+ subsets of natural killer cells: relationship to cytokine production pattern. J Virol. 1993 Oct;67(10):5879–5888. doi: 10.1128/jvi.67.10.5879-5888.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Voth R., Rossol S., Gräff E., Laubenstein H. P., Schröder H. C., Müller W. E., Meyer zum Büschenfelde K. H., Hess G. Natural killer cell activity as a prognostic parameter in the progression to AIDS. J Infect Dis. 1988 Apr;157(4):851–852. doi: 10.1093/infdis/157.4.851. [DOI] [PubMed] [Google Scholar]
  28. Vuillier F., Bianco N. E., Montagnier L., Dighiero G. Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection. AIDS Res Hum Retroviruses. 1988 Apr;4(2):121–129. doi: 10.1089/aid.1988.4.121. [DOI] [PubMed] [Google Scholar]
  29. Vulcano M., Olabuenaga S. E., Galassi N., Felippo M., Perez Bianco R., de Bracco M. M. Inhibition of normal natural killer cytotoxicity by sera from hemophilic patients. Immunol Lett. 1993 May;36(2):153–159. doi: 10.1016/0165-2478(93)90047-6. [DOI] [PubMed] [Google Scholar]
  30. Welsh R. M. Regulation of virus infections by natural killer cells. A review. Nat Immun Cell Growth Regul. 1986;5(4):169–199. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES